Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
02/11/1998 | EP0822984A1 Human tumor necrosis factor receptors |
02/11/1998 | EP0822977A1 Modified cells and methods for inhibiting xenograft rejection |
02/11/1998 | EP0822942A1 Modified anti-icam-1 antibodies and their use in the treatment of inflammation |
02/11/1998 | EP0822941A1 Monoclonal antibodies against hiv-1 and vaccines made thereof |
02/11/1998 | EP0822939A1 Cyclic pentapeptide lh-rh receptor antagonists |
02/11/1998 | EP0822934A1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
02/11/1998 | EP0822834A1 Recombinant (beta)-cell and uses thereof |
02/11/1998 | EP0822832A1 Cd45rb binding compounds for the prevention of transplant rejection |
02/11/1998 | EP0822830A1 Human antibodies derived from immunized xenomice |
02/11/1998 | EP0822829A1 Use of glial neurotrophic factor (gdnf) for treatment of hearing disorders |
02/11/1998 | EP0822828A1 Isolated 55 to 75 kda protein which binds to prion protein |
02/11/1998 | EP0822827A1 Antagonists of lhrh |
02/11/1998 | EP0822826A1 Nitrosylated neuropeptides |
02/11/1998 | EP0730740B1 Kinase receptor activation assay |
02/11/1998 | EP0714407B1 Composition and methods using nitroxides to avoid oxygen toxicity |
02/11/1998 | EP0624164B1 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
02/11/1998 | EP0500734B1 Protein complexes having factor viii:c activity and production thereof |
02/11/1998 | CN1173206A Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus |
02/11/1998 | CN1173204A Immunogens for stimulating mucosal immunity |
02/11/1998 | CN1173203A Purified papillomavirus proteins |
02/11/1998 | CN1173184A Identitication, purification and uses of leczymes and carbohydrate ligands |
02/11/1998 | CN1173183A Conjugates of BDNF and NT-3 with a water-soluble polymer |
02/11/1998 | CN1173174A Substituted oxazolidine calpain and/or cathepsin B inhibitors |
02/11/1998 | CN1173170A Matrix metalloprotease inhibitors |
02/11/1998 | CN1173141A Centrifuge with annular fiter |
02/11/1998 | CN1173140A Method and device for separating hemaleucin fibrin from blood blasma |
02/11/1998 | CN1173136A Method for stimulating erythropoiesis using hematopoietic proteins |
02/11/1998 | CN1172811A Insulin derivatives with increased zinc binding |
02/11/1998 | CN1172591A Dietetic foods and pharmaceutical preparations inhibiting blood coagulation |
02/11/1998 | CN1037350C Method for preparing polypeptide derivative |
02/10/1998 | US5717092 Compounds with improved multi-drug resistance activity |
02/10/1998 | US5717074 Macrophage-derived inflammatory mediator (MIP-2) |
02/10/1998 | US5717073 Anti-gp130 monoclonal antibodies |
02/10/1998 | US5717072 For suppressing immune or inflammatory response in mammals |
02/10/1998 | US5717071 Culture product bactericide specific binding to lipopolysaccharide of outer membrane for treating bacterial infection |
02/10/1998 | US5717070 Culture product |
02/10/1998 | US5717069 Insecticide |
02/10/1998 | US5717067 Purified polypeptide |
02/10/1998 | US5717064 Enhanced resistance to proteolytic digestion |
02/10/1998 | US5717063 Veterinary medicine; nematodes |
02/10/1998 | US5717062 Cyclic analogs of PTH and PTHrP |
02/10/1998 | US5717061 Synthetic antimicobial peptides |
02/10/1998 | US5717058 Viricides, treatment of genetic disorders |
02/10/1998 | US5716981 A stent coated with paclitaxel, a taxan derivative and a polymeric carrier; medical equipment for deblocking |
02/10/1998 | US5716980 Alcohol or aldehyde derivatives and their use |
02/10/1998 | US5716962 Treating hyperglycemia and hyperinsulinemia |
02/10/1998 | US5716957 Administering a hypoglycemic agent or dopaminergic agent once a day and within two hours after waking in morning |
02/10/1998 | US5716937 Method for treating cardiac malfunction |
02/10/1998 | US5716936 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
02/10/1998 | US5716935 Applying polypeptide in carrier to wound to accelerate healing |
02/10/1998 | US5716934 Eck receptor ligands |
02/10/1998 | US5716933 Adjustment the prolactin and glucoccorticosteroid ratio in blood |
02/10/1998 | US5716932 Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates |
02/10/1998 | US5716931 Administering lantibiotic by aerosol |
02/10/1998 | US5716930 Polypeptide from genetically engineered cells |
02/10/1998 | US5716929 Inhibitors of interleukin-1β converting enzyme |
02/10/1998 | US5716928 Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
02/10/1998 | US5716927 Insulin analogs having a modified B-chain |
02/10/1998 | US5716846 Method for inhibiting cellular proliferation using antisense oligonucleotides to interleukin-6 receptor mRNA |
02/10/1998 | US5716838 Culture of microorganisms such as rhizobium, arthrobacter |
02/10/1998 | US5716832 Growing packaging cells having viral protein-coding sequences which produce target cell-specific retroviruses; gene therapy, antitumor agents |
02/10/1998 | US5716827 Capable of regeneration |
02/10/1998 | US5716826 Recombinant retroviruses |
02/10/1998 | US5716823 Human respiratory virus preparahons and processess |
02/10/1998 | US5716817 Dna molecule containing intron sequence; bile salt stimulated lipase or carboxy ester lipase |
02/10/1998 | US5716813 DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses |
02/10/1998 | US5716810 Nucleic acid encoding the mature βB chain of inhibin and method for synthesizing polypeptides using such nucleic acid |
02/10/1998 | US5716806 Genetic engineering; medical diagnosis |
02/10/1998 | US5716805 Methods of preparing soluble, oligomeric proteins |
02/10/1998 | US5716804 Mammalian interleukin-10 (IL-10) super-activating receptors; and variants |
02/10/1998 | US5716789 Incubating cells; measuring activation |
02/10/1998 | US5716787 Immunological detection method for organ transplant rejection |
02/10/1998 | US5716782 Nucleic acid encoding a signal mediator protein that induces cellular morphological alterations |
02/10/1998 | US5716648 Compositions for use in the regulation of subnormal pH values in the intestinal tract and for treatment of bowel diseases |
02/10/1998 | US5716645 Pooled plasma-derived fibrinogen cryoprecipitate free of antifibrinolytic agents, nonhuman proteins and viruses; hemostatic agents, tensile strength |
02/10/1998 | US5716644 Lyophilized solution containing erythropoietin, ammonium sulfate, ph 5-7 buffer |
02/10/1998 | US5716640 Water in oil emulsion |
02/10/1998 | US5716623 Isolated Herpesvirus saimiri proteins that bind MHC Class II molecules |
02/10/1998 | US5716622 Functionally active regions of signal transducer and activators of transcription |
02/10/1998 | US5716619 Treatment of type 2 diabetes mellitus |
02/10/1998 | US5716617 Concurrent purification of mixture |
02/10/1998 | US5716616 Sampling bone marrow; adminstering by intravenous infusion |
02/10/1998 | US5716613 Genetic engineering |
02/10/1998 | US5716612 Desensitizing the cancer cell drug resistance |
02/10/1998 | US5716596 Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses |
02/10/1998 | US5716595 Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments |
02/10/1998 | US5715835 Methods for treating and reducing the potential for cardiovascular disease using methioninase compositions |
02/10/1998 | CA2053258C Use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorption |
02/05/1998 | WO1998004913A1 Molecular model for vla-4 inhibitors |
02/05/1998 | WO1998004727A1 Recombinant pox virus for immunization against tumor-associated antigens |
02/05/1998 | WO1998004719A1 A biovector |
02/05/1998 | WO1998004718A1 Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
02/05/1998 | WO1998004717A2 Double-stranded rna dependent protein kinase derived peptides to promote proliferation of cells and tissues in a controlled manner |
02/05/1998 | WO1998004714A1 A NOVEL HUMAN mRNA EDITING ENZYME |
02/05/1998 | WO1998004712A2 Substrate trapping protein tyrosine phosphatases |
02/05/1998 | WO1998004709A2 Herpes simplex virus icp4 is an inhibitor of apoptosis |
02/05/1998 | WO1998004708A1 Anti-herpesviral agents and assays therefor |
02/05/1998 | WO1998004707A1 Anti-herpesviral agent |
02/05/1998 | WO1998004705A1 Pharmaceutical composition for treating papillomavirus tumours and infection |
02/05/1998 | WO1998004702A2 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use |